AI assistant
GlaxoSmithKline PLC — Director's Dealing 2016
Jun 10, 2016
5262_dirs_2016-06-10_cf1d1aae-a4fb-45ba-ac53-aad5a3c6e854.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 9203A
GlaxoSmithKline PLC
10 June 2016
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons
In accordance with DTR 3.1.4R(1)(a) GlaxoSmithKline plc ('GSK') was advised on 10 June 2016 that the following Directors and Persons Discharging Managerial Responsibilities ('PDMR') acquired GSK Ordinary Shares ('Shares') on 9 June 2016, at a price of 1441.43 pence per Ordinary Share, through GSK's ShareReward Plan (the 'Plan'):
| Director/PDMR | Number of Shares under the personal contribution element of the Plan | Number of Shares under the matching element of the Plan (GSK contribution) |
| Sir Andrew Witty | 9 | 9 |
| Mr R G Connor | 9 | 9 |
| Mr S Dingemans | 9 | 9 |
| Mr N Hirons | 9 | 9 |
| Mr S A Hussain | 9 | 9 |
| Mr D S Redfern | 9 | 9 |
| Ms C Thomas | 9 | 9 |
| Mr P C Thomson | 9 | 9 |
| Dr P J T Vallance | 9 | 9 |
| Ms E Walmsley | 9 | 9 |
| Mrs V A Whyte | 9 | 9 |
V A Whyte
Company Secretary
10 June 2016
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEBLFFQQFZBBQ